SCP
MDT icon

Syntal Capital Partners’s Medtronic MDT Stock Holding History

Syntal Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,913
Closed -$283K – 268
2019
Q2 		$283K Buy
+2,913
New +$266K 0.06% 209
2015
Q4 		– Sell
-508
Closed -$34K – 116
2015
Q3 		$34K Buy
508
+2
+0.4% +$147 0.05% 93
2015
Q2 		$37 Sell
506
-51
-9% -$3.9K 0.04% 112
2015
Q1 		$43K Buy
557
+1
+0.2% +$76 0.05% 104
2014
Q4 		$40K Buy
556
+1
+0.2% +$69 0.02% 126
2014
Q3 		$34K Buy
555
+1
+0.2% +$64 0.02% 132
2014
Q2 		$35K Buy
554
+341
+160% +$20.7K 0.02% 143
2014
Q1 		$13 Buy
+213
New +$12.4K 0.01% 118

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Syntal Capital Partners's MDT Position: Q3 2019 in Review

Syntal Capital Partners sold out of Medtronic (MDT) in Q3 2019, closing a stake of 2,913 shares — an estimated $283K sold.

Syntal Capital Partners first reported a position in MDT in Q1 2014 and held it in 8 quarters. The position peaked at $283K in Q2 2019. 1,644 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Syntal Capital Partners reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Syntal Capital Partners sold 2,913 Medtronic shares in Q3 2019, an estimated $283K.
  • Syntal Capital Partners first reported a position in Medtronic in Q1 2014 and held it in 8 quarters.
  • Syntal Capital Partners's Medtronic position peaked at $283K in Q2 2019.
  • 1,644 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Syntal Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.